Cargando…

Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA

BACKGROUND: Understanding the epidemiological characteristics of various cancers can optimize the prevention and control strategies in the national cancer control plan. This study aimed to report the burden differences, pattern trend, and potential risk factors of all neoplasm types in China in rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaorong, Chen, Hui, Sang, Shaowei, Chen, Hao, Li, Lanbo, Yang, Xiaoyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178089/
https://www.ncbi.nlm.nih.gov/pubmed/35692329
http://dx.doi.org/10.3389/fpubh.2022.862165
_version_ 1784722979427450880
author Yang, Xiaorong
Chen, Hui
Sang, Shaowei
Chen, Hao
Li, Lanbo
Yang, Xiaoyun
author_facet Yang, Xiaorong
Chen, Hui
Sang, Shaowei
Chen, Hao
Li, Lanbo
Yang, Xiaoyun
author_sort Yang, Xiaorong
collection PubMed
description BACKGROUND: Understanding the epidemiological characteristics of various cancers can optimize the prevention and control strategies in the national cancer control plan. This study aimed to report the burden differences, pattern trend, and potential risk factors of all neoplasm types in China in recent 30 years, and further compared with top economies in the world. METHODS: The disability-adjusted life-years (DALYs) and age-standardized DALY rate (ASDR) of all neoplasms with the attributable risk factors from 1990 to 2019 in China, Japan, European Union, USA, and the world were extracted from the Global Burden of Disease Study 2019. The temporal trend analysis was estimated using the joinpoint regression model. RESULTS: In 2019, about 251.4 million DALYs worldwide were caused by all neoplasms, and nearly 26.9% (67.5 million DALYs) occurred in China with the ASDR in 2019 of 342.09/10 000, which was higher than European Union (334.25/10 000), USA (322.94/10 000), and Japan (250.36/10 000). Although the cancer burden of the colorectum, non-Hodgkin lymphoma, oral cavity, ovary, and kidney in China was lower than in Japan, European Union and USA, the corresponding ASDR gradually increased in China over the past 30 years, but declined in the three developed areas. Around 46.29% of overall neoplasms DALYs in China in 2019 were attributed to 22 identified risk factors, and the specific risk attributable-fraction for several neoplasm types varied greatly in these regions. CONCLUSION: The ASDR of cancers of the lung, colorectum, pancreas, non-Hodgkin lymphoma, oral cavity, ovary, kidney, and chronic lymphoid leukemia increased in China compared to 30 years ago. With the population aging and the social transformation in China, the increasing burden of neoplasms and the changing spectrum of neoplasms suggest that effective comprehensive prevention and treatment measures should be adopted to reduce the burden, including public health education, strict tobacco-control policy, healthier lifestyles, along with expanding vaccination programs and early cancer screening.
format Online
Article
Text
id pubmed-9178089
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91780892022-06-10 Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA Yang, Xiaorong Chen, Hui Sang, Shaowei Chen, Hao Li, Lanbo Yang, Xiaoyun Front Public Health Public Health BACKGROUND: Understanding the epidemiological characteristics of various cancers can optimize the prevention and control strategies in the national cancer control plan. This study aimed to report the burden differences, pattern trend, and potential risk factors of all neoplasm types in China in recent 30 years, and further compared with top economies in the world. METHODS: The disability-adjusted life-years (DALYs) and age-standardized DALY rate (ASDR) of all neoplasms with the attributable risk factors from 1990 to 2019 in China, Japan, European Union, USA, and the world were extracted from the Global Burden of Disease Study 2019. The temporal trend analysis was estimated using the joinpoint regression model. RESULTS: In 2019, about 251.4 million DALYs worldwide were caused by all neoplasms, and nearly 26.9% (67.5 million DALYs) occurred in China with the ASDR in 2019 of 342.09/10 000, which was higher than European Union (334.25/10 000), USA (322.94/10 000), and Japan (250.36/10 000). Although the cancer burden of the colorectum, non-Hodgkin lymphoma, oral cavity, ovary, and kidney in China was lower than in Japan, European Union and USA, the corresponding ASDR gradually increased in China over the past 30 years, but declined in the three developed areas. Around 46.29% of overall neoplasms DALYs in China in 2019 were attributed to 22 identified risk factors, and the specific risk attributable-fraction for several neoplasm types varied greatly in these regions. CONCLUSION: The ASDR of cancers of the lung, colorectum, pancreas, non-Hodgkin lymphoma, oral cavity, ovary, kidney, and chronic lymphoid leukemia increased in China compared to 30 years ago. With the population aging and the social transformation in China, the increasing burden of neoplasms and the changing spectrum of neoplasms suggest that effective comprehensive prevention and treatment measures should be adopted to reduce the burden, including public health education, strict tobacco-control policy, healthier lifestyles, along with expanding vaccination programs and early cancer screening. Frontiers Media S.A. 2022-05-26 /pmc/articles/PMC9178089/ /pubmed/35692329 http://dx.doi.org/10.3389/fpubh.2022.862165 Text en Copyright © 2022 Yang, Chen, Sang, Chen, Li and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Yang, Xiaorong
Chen, Hui
Sang, Shaowei
Chen, Hao
Li, Lanbo
Yang, Xiaoyun
Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA
title Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA
title_full Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA
title_fullStr Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA
title_full_unstemmed Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA
title_short Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA
title_sort burden of all cancers along with attributable risk factors in china from 1990 to 2019: comparison with japan, european union, and usa
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178089/
https://www.ncbi.nlm.nih.gov/pubmed/35692329
http://dx.doi.org/10.3389/fpubh.2022.862165
work_keys_str_mv AT yangxiaorong burdenofallcancersalongwithattributableriskfactorsinchinafrom1990to2019comparisonwithjapaneuropeanunionandusa
AT chenhui burdenofallcancersalongwithattributableriskfactorsinchinafrom1990to2019comparisonwithjapaneuropeanunionandusa
AT sangshaowei burdenofallcancersalongwithattributableriskfactorsinchinafrom1990to2019comparisonwithjapaneuropeanunionandusa
AT chenhao burdenofallcancersalongwithattributableriskfactorsinchinafrom1990to2019comparisonwithjapaneuropeanunionandusa
AT lilanbo burdenofallcancersalongwithattributableriskfactorsinchinafrom1990to2019comparisonwithjapaneuropeanunionandusa
AT yangxiaoyun burdenofallcancersalongwithattributableriskfactorsinchinafrom1990to2019comparisonwithjapaneuropeanunionandusa